|Publication number||US7899526 B2|
|Application number||US 11/127,055|
|Publication date||Mar 1, 2011|
|Filing date||May 10, 2005|
|Priority date||May 10, 2004|
|Also published as||CA2567769A1, EP1761165A2, EP1761165A4, US20050267381, US20070021683, WO2005110051A2, WO2005110051A3|
|Publication number||11127055, 127055, US 7899526 B2, US 7899526B2, US-B2-7899526, US7899526 B2, US7899526B2|
|Inventors||David G. Benditt, Robert F. Patterson, Keith G. Lurie|
|Original Assignee||Regents Of The University Of Minnesota|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (34), Non-Patent Citations (5), Referenced by (19), Classifications (26), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is based on and claims the benefit of U.S. Provisional Patent Application No. 60/569,551, filed May 10, 2004, the entire disclosure of which is incorporated herein by reference.
The present invention relates to diagnostic monitoring systems and, more particularly, to a portable diagnostic monitoring system for assessing cardiovascular hemodynamic state during the setting of a normal or abnormal heart rhythm. Advantageously, the monitoring system is capable of detecting abnormalities of blood pressure and/or flow.
Changes in cardiac output or blood pressure may be of value in diagnosis and management chronic and/or recurring disease states (e.g., congestive heart failure, hypertension, syncope). Currently, such measurements require invasive intravascular catheters with attached sensors (e.g., pressure, oxygen saturation) or an intra-arterial cannula.
Devices employing the technique of impedance plethysmography (commonly known as Impedance Cardiographs (ICG) when applied to the thorax) have been developed which are external to the body and can provide a surrogate marker of pulsatile blood volume changes and/or surrogate measure of blood flow by detection of changes in bioelectrical impedance (BEI). Typically, these devices use band or spot electrodes around the ends of the thorax and measure change in chest impedance due to altered vascular volumes corresponding to cardiac activity. Current is transmitted through the chest and seeks the path of least resistance, i.e., the blood filled aorta. With each heartbeat, the blood volume and velocity of the aorta change. Impedance plethysmography measures the corresponding change in impedance and calculates the hemodynamic parameters.
The invention addresses the medical problem of evaluating the hemodynamic impact of a cardiac arrhythmia or suspected cardiac arrhythmia in free-living individuals. The objective may be accomplished by correlating electrocardiographic (ECG) recordings with surrogate measurements of blood pressure and/or blood flow obtained from a portable (wearable or insertable) cardiac monitor. In essence, for instances in which there is suspicion that heart rhythm disturbances are causing symptoms (e.g., dizziness, syncope, or weakness), the ability to correlate a documented arrhythmia with its hemodynamic effect will allow the physician to better assess the true impact of the arrhythmia on the patient. Additionally, some patients may exhibit hemodynamic disturbances (e.g., abrupt hypotension) without concomitant arrhythmia. Examples include certain vasodepressor faints in which the main problem is dilation of arterial blood vessels causing a fall in blood pressure, or in some individuals in association with movement from supine or seated to upright posture (e.g., orthostatic hypotension and/or orthostatic faints). In these conditions the heart rhythm may remain normal, or only relatively minor abnormalities are recorded and the heart rate may remain within the normal range; nonetheless, the blood pressure becomes abnormally low. Currently, these latter conditions are difficult to document in free-living individuals as they occur unpredictably over time, and at present there is no available portable monitor systems which can document both ECG and hemodynamic alterations over relatively long periods (e.g., weeks or months).
Embodiments of the present invention are directed to a physiological monitoring device which is configured to record signals that reflect blood flow and/or blood pressure, and which may also record ECG signals. In an exemplary embodiment, a portable diagnostic monitoring device is capable of detecting abnormal cardiac rhythms and assess their impact on blood flow, as well as detect abnormalities of blood flow that may or may not be associated with an abnormal heart rhythm. An example of clinical use is the evaluation of individuals experiencing syncope (faints) of unknown origin. The monitoring device may be worn on the body surface of the patient. A more practical embodiment of the monitoring device is of a sufficiently small size as to be insertable into the body of the patient using techniques essentially identical to placement of a conventional pacemaker generator. In the exemplary embodiment, intra-vascular access is not utilized, so that the system offers diagnostic capabilities without invading blood vessels to insert sensors. In other embodiments, intravascular or extravascular leads may be used to enhance the diagnostic capability. In yet other embodiments, the monitoring device may be incorporated into a conventional pacemaker or implantable defibrillator (ICD) to enhance the diagnostic capability of those instruments.
In accordance with an aspect of the present invention, a portable monitoring device comprises a plurality of impedance electrodes configured to be coupled to a patient's body and to generate an AC current with an electrical field to detect local electrical impedance of a portion of the patient's body encompassed by the electrical field, the local electrical impedance being a surrogate measure of local blood flow of the portion of the patient's body. At least a portion of the portable monitoring device is configured to be insertable subcutaneously into the patient's body.
In some embodiments, the impedance electrodes are to be placed in close proximity to (e.g., within less than about 5 cm of) a target region of the patient's body to be monitored. The impedance electrodes are configured to detect local electrical impedance near an artery in the patient's body. The impedance electrodes include two electrodes that are spaced from one another in a direction generally parallel to or transversely across the artery. A temperature sensor may also be used in this device to aid in assessing local blood flow and/or monitoring for recurring disease states that may cause fever. The temperature sensor is configured to measure local tissue temperature of the patient's body near the temperature sensor. A plurality of ECG electrodes are configured to be coupled to the patient's body. A telemetry component is configured to communicate telemetrically with an external device. A warning component, which may be activated or deactivated by an external telemetry link, provides warning based on the detected information. The impedance electrodes are can-mounted surface electrodes. Auxiliary leads are coupled with the impedance electrodes.
In specific embodiments, a memory is configured to store physiological information obtained by detecting the local electrical impedance by the impedance electrodes. The memory is configured to store physiological data based on instructions delineating criteria for data to be stored. The memory has looping memory capability. The memory is configured to store data temporally proximate to an event based on information detected by the impedance electrodes or patient-activated triggering.
In accordance with another aspect of the present invention, a portable monitoring device comprises a plurality of impedance electrodes configured to be coupled to a patient's body and to generate an AC current with an electrical field to detect local electrical impedance of a portion of the patient's body encompassed by the electrical field; a plurality of ECG electrodes configured to be coupled to the patient's body; and a memory configured to store physiological information obtained by detecting the local electrical impedance by the impedance electrodes and by the ECG electrodes.
In some embodiments, the impedance electrodes and the ECG electrodes are can-mounted surface electrodes. Auxiliary leads may also be coupled with at least some of the impedance electrodes and the ECG electrodes.
In accordance with another aspect of the invention, a method of monitoring a patient comprises coupling a plurality of impedance electrodes to a patient's body to generate an AC current with an electrical field to detect local electrical impedance of a portion of the patient's body encompassed by the electrical field, the local electrical impedance being a surrogate measure of local blood flow of the portion of the patient's body; and inserting at least a portion of a portable monitoring device including the impedance electrodes subcutaneously into the patient's body.
In some embodiments, the impedance electrodes are placed in the vicinity (e.g., usually within less than about 5 cm) of a target region of the patient's body to be monitored (e.g., an artery such as the subclavian artery). The impedance electrodes may be applied to a muscle of the patient's body to be monitored. Two of the impedance electrodes may be positioned near an artery and spaced in a direction generally parallel to the artery. Local tissue temperature of the patient's body may also be measured. ECG data of the patient may also be measured. The method may further include transferring information obtained by the impedance electrodes and other sensors (e.g., temperature sensors, ECG electrodes) to an external device disposed outside the patient's body. A warning is generated based on the detected information using pre-determined criteria programmed into the device by the user (e.g., physician). The method further comprises storing physiological information obtained by detecting the local electrical impedance by the impedance electrodes. The information is stored based on instructions delineating criteria for data to be stored. The information is stored proximate to an event based on information detected by the impedance electrodes or patient-activated triggering.
In specific embodiments, the method further comprises coupling auxiliary leads to the impedance electrodes and positioning the auxiliary leads in a target location in the patient's body. The method may further comprise providing the impedance electrodes in an implantable diagnostic device.
A further configuration permits automatic telemetry of information to an external receiver/transmitter for automatic transfer to a distant monitoring station such as by radiowaves, wireless telephony, or direct internet connection.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
The impedance electrodes 12 are configured to transmit electrical signals and/or measure the resulting local electrical impedance as it is determined by the signals passing through tissue and/or blood vessels in the vicinity of the impedance electrodes 12, as encompassed by an electrical field of an AC current generated by the impedance electrodes 12. More particularly, the impedance electrodes 12 can measure surrogates of the local blood flow characteristics (e.g., blood flow volume or velocity) of the local tissue zone and, more precisely, the pulsatile blood volume change in the muscle in the local tissue zone being sampled. The impedance electrodes 12 generate an AC current with an electrical field that encompasses the local tissue zone being sampled to measure voltage drop therebetween. The voltage drop depends on the impedance corresponding to the pulsation of blood. The blood flow oscillates over time, and intermittently changes the impedance over time. For instance, the impedance may represent the relative magnitudes of blood flow (increasing or decreasing), or may be a relative measure of the blood flow (volume and/or velocity) with respect to an earlier time. The local impedance change is expected to be proportional to changes in the pulsatile blood volume change in the muscle in the tissue zone being sampled. A minimum of two impedance electrodes 12 are used. Additional impedance electrodes 12 allow different impedance or voltage drop vectors to be generated to provide a better chance of detecting changes in the blood flow characteristics.
In some embodiments, the impedance electrodes 12 are configured to be disposed near the artery or arteries being monitored, typically separated by less than about 5 cm, more desirably about 3-4 cm. The distance depends on the strength of the electrical field of the AC current being generated, and can increase with an increase in the strength of the electrical field. The artery 30 may be disposed generally parallel to the spacing between two impedance electrodes (e.g.,
It is noted, however, that the impedance electrodes 12 are configured to be applied over any target region on a patient's body for detecting a surrogate marker of pulsatile blood volume changes or blood flow. The target region may be the muscle of the body or some tissue region. In that case, the impedance electrodes 12 need not be placed in the vicinity of any arteries.
The temperature sensor 16 measures local tissue temperature which may be a surrogate marker for blood pressure and/or blood flow measurement. The sensor 16 can detect flow-related temperature differences. A sensitive recording system is preferably used. For instance, an abrupt local temperature change may reasonably be interpreted as being due to acute changes in local blood flow. Slow temperature changes may reflect environmental factors, or a fever, etc. Rapid temperature changes, albeit of a small magnitude, is most likely related to blood flow alterations.
The ECG electrodes 14 increase the clinical utility of the monitoring device 10 by recording one or more ECG lead vectors. The data collected by the ECG electrodes 14 may be used to correlate with the data collected by the impedance electrodes 12 and/or the temperature sensor 16 to assist physicians in distinguishing whether cardiac arrhythmias are responsible for hypotensive symptoms or other mechanisms are at fault. Other sensors may be used to detect flow change utilizing, for example, laser Doppler techniques (photoplethysmography) or local detection of hemoglobin by reflectance methods.
As seen in
In specific embodiments, the monitoring device 10 is inserted into the body of the patient under the skin, more typically under the subcutaneous tissue. For example, the monitoring device 10 may be inserted subcutaneously under the collar bone to be disposed near the subclavian artery. If the monitoring device 10 is inserted to place the impedance electrodes 12 against the pectoralis muscles, a surrogate assessment of skeletal muscle blood flow will be the target to be monitored. An insertable monitoring device is more practical than a wearable one for long term use because it eliminates the need to attach electrodes or the like onto the external skin surface of the patient. In yet another embodiment, the monitoring device 10 may be incorporated into an implantable device such as a cardiac pacemaker, an implantable defibrillator (ICD), or the like to provide additional diagnostic or hemodynamic feedback capability (see, e.g., U.S. Pat. No. 5,441,525).
In specific embodiments, the memory capability of the monitoring device 10 is “looping” (first in, first out) with programmable durations of the “loop” permitting the saving of information prior to automatic or patient-activated triggering of the recordings. Programmability will be such as to permit all or only a subset of detected signals to be stored for subsequent immediate or later transmission to the body surface of the patient, and ultimately to medical personnel for interpretation (e.g., by wireless telephony). For instance, the monitoring device 10 can be programmed to save data temporally proximate certain events (just before and just after), such as an abrupt substantial change in surrogate measures of blood flow (e.g., impedance or temperature).
The patient may be offered a custom-programmed hand-held PDA (personal digital assistant) or a similar external device 200, as illustrated in
The monitoring device does not require intra-vascular access. For long-term (weeks or months) cardiac monitoring, this offers previously unavailable data, ease of use, and enhanced safety compared to intra-vascular applications. The result is the ability to assess, at least qualitatively, the hemodynamic impact of heart rhythm disturbances in free-living individuals. Similarly, the monitoring device offers the potential to document heart rhythm and tissue blood flow surrogates (e.g., tissue impedance, temperature) during periods of hypotension of non-cardiac cause, thereby helping to assess the possibility of a cardiac and/or vascular cardiac etiology during diagnostic evaluation of patients. This portable diagnostic device is capable, without use of intra-cardiac electrodes, of diagnosing hemodynamic perturbations and ascertaining whether and to what degree they are caused by cardiac rhythm disturbances. At the same time, the device can be enhanced by adding non-vascular or intra-vascular leads for placing sensors at more distance sites in the body, or can be incorporated as a diagnostic element within a conventional cardiac pacemaker, ICD, or other implanted diagnostic instrument.
It is recognized that tissue blood flow may vary with respiration, posture, altered cardiac output, or changes in vascular tone. However, for patients in whom heart monitoring of the type discussed herein is selected (i.e., those with suspected arrhythmias or syncope), an abrupt substantial change in surrogate measures of blood flow may reasonably be expected to be due to an arrhythmia or other abrupt hypotensive state. Thus, detection of suspected flow alterations, along with ECG correlation, will assist physicians in distinguishing whether cardiac arrhythmias (i.e., abnormally slow or fast heart rates) are responsible for hypotensive symptoms or whether other mechanisms (e.g., vasodepressor hypotension without arrhythmia) are at fault. In many instances, hypotension occurs without evident arrhythmia. The present monitoring device is designed to detect this type of clinical problem in free-living individuals.
From the foregoing, it will be apparent to those skilled in the art that the present invention provides, in exemplary non-limiting embodiments, a wide variety of design options for the electrodes, sensors, leads, and the like for the monitoring device. Further, those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4774950||Oct 6, 1987||Oct 4, 1988||Leonard Bloom||Hemodynamically responsive system for and method of treating a malfunctioning heart|
|US4846191||May 27, 1988||Jul 11, 1989||Data Sciences, Inc.||Device for chronic measurement of internal body pressure|
|US4899751||Jul 12, 1989||Feb 13, 1990||Leonard Bloom||System for and method of therapeutic stimulation of a patient's heart|
|US5269301||Oct 19, 1992||Dec 14, 1993||Leonard Bloom||Multimode system for monitoring and treating a malfunctioning heart|
|US5431685||Jul 29, 1994||Jul 11, 1995||Intermedics, Inc.||Implantable medical interventional device with criteria modification to enhance recognition of Tachycardia|
|US5441525||May 20, 1994||Aug 15, 1995||Medtronic, Inc.||Pacemaker with vasovagal syncope detection|
|US5487760||Mar 8, 1994||Jan 30, 1996||Ats Medical, Inc.||Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry|
|US5865749||Nov 7, 1996||Feb 2, 1999||Data Sciences International, Inc.||Blood flow meter apparatus and method of use|
|US5913879||May 8, 1996||Jun 22, 1999||Pacesetter Ab||Venous pooling detection and therapy device|
|US5957861 *||Jan 31, 1997||Sep 28, 1999||Medtronic, Inc.||Impedance monitor for discerning edema through evaluation of respiratory rate|
|US6033366||Oct 14, 1997||Mar 7, 2000||Data Sciences International, Inc.||Pressure measurement device|
|US6259936||Feb 18, 1998||Jul 10, 2001||Moor Instruments Limited||Apparatus for imaging blood flow in the microcirculation|
|US6351670||Sep 8, 1999||Feb 26, 2002||Galvani, Ltd.||Electrical cardiac assist for an implantable syncope monitor|
|US6477406||Apr 5, 2000||Nov 5, 2002||Pacesetter, Inc.||Extravascular hemodynamic acoustic sensor|
|US6480733||Dec 17, 1999||Nov 12, 2002||Pacesetter, Inc.||Method for monitoring heart failure|
|US6491639||Apr 5, 2000||Dec 10, 2002||Pacesetter, Inc.||Extravascular hemodynamic sensor|
|US6510342||Apr 12, 2000||Jan 21, 2003||Pacesetter, Inc.||Methods and apparatus for preventing atrial arrhythmias by overdrive pacing multiple heart tissue sites using an implantable cardiac stimulation device|
|US6512949 *||Jul 12, 1999||Jan 28, 2003||Medtronic, Inc.||Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto|
|US6527729||Oct 11, 2000||Mar 4, 2003||Pacesetter, Inc.||Method for monitoring patient using acoustic sensor|
|US6561948||Mar 21, 2001||May 13, 2003||Eaton Corporation||Control for transmission system utilizing centrifugal clutch|
|US6561986 *||Jan 17, 2001||May 13, 2003||Cardiodynamics International Corporation||Method and apparatus for hemodynamic assessment including fiducial point detection|
|US6575912||Oct 16, 2001||Jun 10, 2003||Pacesetter, Inc.||Assessing heart failure status using morphology of a signal representative of arterial pulse pressure|
|US6575914||May 18, 2001||Jun 10, 2003||Koninklijke Philips Electronics N.V.||Integrated cardiac resuscitation system with ability to detect perfusion|
|US6600949||May 5, 2000||Jul 29, 2003||Pacesetter, Inc.||Method for monitoring heart failure via respiratory patterns|
|US6616624||Oct 30, 2000||Sep 9, 2003||Cvrx, Inc.||Systems and method for controlling renovascular perfusion|
|US6625492||May 3, 2001||Sep 23, 2003||Pacesetter, Inc.||Implantable cardiac stimulation device with detection and therapy for patients with vasovagal syncope|
|US6647295||May 3, 2001||Nov 11, 2003||Pacesetter, Inc.||Implantable cardiac stimulation device with detection and therapy for patients with vasovagal syncope|
|US6662047||Sep 5, 2001||Dec 9, 2003||Pacesetter, Inc.||Pacing mode to reduce effects of orthostatic hypotension and syncope|
|US7097618||Mar 9, 2004||Aug 29, 2006||Transoma Medical, Inc.||Devices and methods for detecting and treating inadequate tissue perfusion|
|US20020072731||Dec 12, 2000||Jun 13, 2002||Data Sciences International, Inc.||Adjustable flow probe|
|US20020107559||Nov 5, 2001||Aug 8, 2002||Cameron Health, Inc.||Method and device for insertion and implantation of a subcutaneous electrode|
|US20030229380||Oct 31, 2002||Dec 11, 2003||Adams John M.||Heart failure therapy device and method|
|WO1998051212A1||May 13, 1998||Nov 19, 1998||Colin Dunlop||Method and apparatus for monitoring haemodynamic function|
|WO2005110051A2||May 10, 2005||Nov 24, 2005||Transoma Medical, Inc.||Portable device for monitoring electrocardiographic signals and indices of blood flow|
|1||International Preliminary Report on Patentability of Nov. 14, 2006 for PCT application PCT/US05/16396.|
|2||International Search Report of Jun. 13, 2006 for PCT application PCT/US05/16396.|
|3||Moya et al., "Mechanism of Syncope in Patients With Isolated Syncope and in Patients With Tilt-Positive Syncope", Circulation 2001; 104; 1261-1267.|
|4||Priebe, Hans-Joachim, "Vasoactive Drugs", IARS 2004 Review Course Lectures, pp. 64-70.|
|5||Written Opinion of Jun. 13, 2006 for PCT application PCT/US05/16396.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8011367||Feb 27, 2007||Sep 6, 2011||Advanced Circulatory Systems, Inc.||CPR devices and methods utilizing a continuous supply of respiratory gases|
|US8151790||Oct 12, 2007||Apr 10, 2012||Advanced Circulatory Systems, Inc.||Volume exchanger valve system and method to increase circulation during CPR|
|US8255041||Feb 3, 2011||Aug 28, 2012||Lifesync Corporation||Wireless ECG system|
|US8868185||Nov 27, 2012||Oct 21, 2014||Medtronic, Inc.||Use of thoracic and extra-thoracic impedance for diagnostic monitoring|
|US8967144||Jun 21, 2010||Mar 3, 2015||Advanced Circulatory Systems, Inc.||Vacuum and positive pressure ventilation systems and methods for intrathoracic pressure regulation|
|US8985098||Mar 2, 2012||Mar 24, 2015||Advanced Circulatory Systems, Inc.||CPR volume exchanger valve system with safety feature and methods|
|US9060708||Jul 25, 2014||Jun 23, 2015||Proteus Digital Health, Inc.||Multi-mode communication ingestible event markers and systems, and methods of using the same|
|US9083589||Mar 6, 2014||Jul 14, 2015||Proteus Digital Health, Inc.||Active signal processing personal health signal receivers|
|US9198608||Nov 23, 2011||Dec 1, 2015||Proteus Digital Health, Inc.||Communication system incorporated in a container|
|US9238115||Dec 19, 2012||Jan 19, 2016||ResQSystems, Inc.||Systems and methods for therapeutic intrathoracic pressure regulation|
|US9258035||Apr 29, 2015||Feb 9, 2016||Proteus Digital Health, Inc.||Multi-mode communication ingestible event markers and systems, and methods of using the same|
|US9352111||Oct 23, 2014||May 31, 2016||Advanced Circulatory Systems, Inc.||Systems and methods to increase survival with favorable neurological function after cardiac arrest|
|US9433371||Jan 22, 2014||Sep 6, 2016||Proteus Digital Health, Inc.||In-body device with virtual dipole signal amplification|
|US9444503||Jun 10, 2015||Sep 13, 2016||Proteus Digital Health, Inc.||Active signal processing personal health signal receivers|
|US20070221222 *||Feb 27, 2007||Sep 27, 2007||Advanced Circulatory Systems, Inc.||Cpr devices and methods utilizing a continuous supply of respiratory gases|
|US20080047555 *||Sep 26, 2007||Feb 28, 2008||Advanced Circulatory Systems, Inc.||Bag-valve resuscitation for treating of hypotension, head trauma, and cardiac arrest|
|US20080257344 *||Oct 12, 2007||Oct 23, 2008||Advanced Circulatory Systems, Inc.||Volume exchanger valve system and method to increase circulation during cpr|
|US20100319691 *||Jun 21, 2010||Dec 23, 2010||Advanced Circulatory Systems, Inc.||Vacuum and positive pressure ventilation systems and methods for intrathoracic pressure regulation|
|US20110160604 *||Feb 3, 2011||Jun 30, 2011||Rud Istvan||Wireless ecg system|
|U.S. Classification||600/547, 600/504, 600/506, 600/481|
|International Classification||A61B5/026, A61B5/00, A61B5/053, A61B5/04, A61B5/021, A61B5/02, A61B5/0464, A61B5/05, A61B5/0205|
|Cooperative Classification||A61B5/0464, A61B5/0031, A61B5/0535, A61B5/021, A61B5/6837, A61B5/02028, A61B5/026, A61B5/02055|
|European Classification||A61B5/0464, A61B5/053F, A61B5/026, A61B5/68B3J, A61B5/02F|
|Aug 5, 2005||AS||Assignment|
Owner name: TRANSOMA MEDICAL, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BENDITT, DAVID;PATTERSON, ROBERT;LURIE, KEITH G.;REEL/FRAME:016361/0131;SIGNING DATES FROM 20050720 TO 20050801
Owner name: TRANSOMA MEDICAL, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BENDITT, DAVID;PATTERSON, ROBERT;LURIE, KEITH G.;SIGNINGDATES FROM 20050720 TO 20050801;REEL/FRAME:016361/0131
|May 25, 2007||AS||Assignment|
Owner name: REGENTS OF THE UNIVERSITY OF MINNESOTA, MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRANSOMA MEDICAL, INC.;REEL/FRAME:019347/0265
Effective date: 20070524
|Sep 27, 2011||CC||Certificate of correction|
|Sep 1, 2014||FPAY||Fee payment|
Year of fee payment: 4